Special
Special
-
After toasting Liverpool, City shows what might have been
"How is it possible," the coach of Liverpool's champions asked himself recently, "that anybody is 20 points ahead of this team?"
-
Emami, HUL locked in 'handsome' fight
As Emami threatens legal action against HUL over the use of the name 'Glow & Handsome' in its men's range of fairness cream, Forbes India digs into the history of the fairness war between the two FMCG giants
-
Intel Capital partners with Jio Platforms
The investment coincides with the launch of Jio Meet, a video-conferencing app that is currently free to use, and can accommodate up to 100 people
-
Novartis will pay a $678 million settlement for doctor kickbacks
After admitting it used an extensive kickback program for nearly a decade to influence doctors to prescribe certain medications, Novartis will pay up to settle a fraud lawsuit, federal prosecutors in New York announced Wednesday
-
President Trump has tools to pressure China. Will he use them?
Opinion: History will not be kind to those who did nothing to try to stop Beijing's human rights abuses
-
Vodafone Idea posts massive fiscal year and Q4FY20 losses
Subscriber base falls by further 4.2%; the company acknowledges cause for concerns and warns of impact of AGR case
-
After a staggering rally, what's next for stocks?
During the first six months of the year, stocks experienced their biggest quarter-to-quarter swing in more than 80 years. The second half could go either way
-
HUL AGM: Covid-19 crisis in focus
Shareholders at Hindustan Unilever grilled the management on its handling of the pandemic
-
.jpg?impolicy=website&width=266&height=200 "startups")
Covid-19 vaccine: Bharat Biotech to start human trials
What you need to know about Covaxin, the first Indian-made coronavirus vaccine candidate that's been approved for human trials
-
.jpg?impolicy=website&width=266&height=200 "startups")
What Chinese apps stand to lose from India
Some of the most popular Chinese apps, including TikTok and Helo, are set to lose millions of users. A look at what's on stake, and how they compare with other apps